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Background/introduction
The Blood Brain Barrier (BBB) in Non-Human Primates
(NHP) can be non-invasively opened through the use of
Focused Ultrasound (FUS) in conjunction with microbub-
bles. This procedure allows for a targeted, transient open-
ing in the BBB of the NHP which can be utilized to
facilitate drug delivery. While FUS has been used to deliver
various pharmacological compounds to promote neuro-
genesis or treat cancer, no group has investigated if drug
delivery can affect behavioral responses. In this study, we
show the effects of targeted ME-FUS drug delivery on the
responses of NHP to a decision making task.
Methods
The ME-FUS procedure was conducted on three (n = 3)
NHP under general anesthesia (isoflurane) and in
stereotactical positioning to ensure accurate targeting.
Microbubbles (4-5 um, in-house prepared) were admi-
nistered IV at the onset of applying the FUS (Single ele-
ment transducer, 500 kHz, 0.3-0.4 Mpa, 10 ms pulse
length, 120 second duration). The putamen region of the
basal ganglia was targeted for all behavioral experiments.
After the ME-FUS procedure there was a three hour
recovery period allowing the NHP to fully recover normal
motor functions impaired from the general anesthesia.
IM injections of haloperidol (D2 antagonist, 0.01mg/kg)
in the awake monkey were administered five minutes
prior to the start of behavioral testing. The NHPs were
trained to complete a reward magnitude bias and dot
direction coherence task for water reward. One day after
the ME-FUS procedure BBB opening and safety of
the procedure was verified with contrast enhanced
T1-weighted and T2-weighted MRI scans respectively.
Results and conclusions
The BBB was successfully opened in the putamen region of
each NHP for all ME-FUS procedures. No damage from
the ME-FUS procedure was detected with the T2-weighted
MRI scans. Delivery of haloperidol after BBB opening was
shown to nullify a significant difference of reaction time
between the contralateral and ipsilateral hands to the ME-
FUS procedure observed with the saline controls. This sig-
nificant difference in reaction time between hands was
observed when haloperidol was administered without BBB
opening. Delivery of haloperidol after BBB opening also
negated a significant difference in reaction time between
the high and low reward cues observed with the saline con-
trols. Overall preliminary results show that FUS-induced
BBB opening in NHP can be used to facilitate delivery of
D2 antagonists to the putamen region causing significant
effects on motivation and reaction time.
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